Arsenic-Induced Apoptosis in Malignant Cells In vitro

References

• Chen C.J., Wu M.M., Lee S.S., Wang J.D., Cheng S.H., Wu H.Y. Atherogenicity and carcinogenecity of high-arsenicartesian well water: Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1998; 8: 452–460
   Google Scholar
• Chen C.J., Chen C.W., Wu M.M., Kuo T.L. Cancer potential in liver, lung, Bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 1992; 66: 888–892
   PubMed Web of Science ®Google Scholar
• Lee T.C., Wei M.L., Chang W.J., Ho I.C., Lo J.F., Jan K.Y., Huang H. Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster overy cells. In Vitro Cell Dev. Biol. 1989; 25: 442–447
   PubMed Web of Science ®Google Scholar
• Ochi T., Nakajima F., Sakurai T., Kaise T., Oya-Ohta Y. Dimetylarsenic acid causes apoptosis in HL-60 cells via interaction with glutathione. Arch. Toxicol. 1996; 70: 815–821
   PubMed Web of Science ®Google Scholar
• Wang T.S., Kuo C.F., Jan K.Y., Huang H. Arsenite induces apoptosis in Chinese Hamster overy cells by generation of reactive oxygen species. J. Cell Physiol. 1996; 169: 256–268
   PubMed Web of Science ®Google Scholar
• Nordenson I., Beckman L. Is the genotoxic effect of arsenic mediated by oxygen free radical?. Hum. Hered. 1991; 41: 71–73
   PubMed Web of Science ®Google Scholar
• Hartwig A., Groblinghoff U.D., Beyersman D., Natarajan A.T., Filon R., Mullenders L.H.F. Interaction of arsenic (II) with nucleotide excision repair on UV-irradiated human fibroblasts. Carcinogenesis 1997; 18: 399–405
   PubMed Web of Science ®Google Scholar
• Cantoni O., Hussain S., Guidarelli A., Cattabeni F. Cross-resistance to heavy metals in hydrogen peroxide-resistant CHO cell variants. Mutat. Res. 1994; 324: 1–6
   PubMed Web of Science ®Google Scholar
• Wang T.S., Huang H. Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis 1996; 9: 253–257
   Web of Science ®Google Scholar
• DiPietrantonio A.M., Hsieh T., Wu J.M. Activation of caspase 3 in HL-60 cells exposed to hydrogen peroxide. Biochem. Biophys. Res. Comm. 1999; 255: 477–482
   PubMed Web of Science ®Google Scholar
• Shen Z.X., Chen G.Q., Ni J.H., Li X.S., Xiong S.M., Qiu Q.Y., Zhu J., Tang W., Sun G.L., Yang K.Q., Chen Y., Zhou L., Fang Z.W., Wang Y.T., Ma J., Zhang P., Zhang T.D., Chen S.J., Chen Z., Wang Z.Y. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354–3360
   PubMed Web of Science ®Google Scholar
• Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Carso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell R.P., Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 1998; 339: 1341–1348
   PubMed Web of Science ®Google Scholar
• Chen G.Q., Zha J., Shi X.G., Ni J.H., Zhong H.J., Si G.Y., Jin X.L., Tang W., Li X.S., Xong S.M., Shen Z.X., Sun G.L., Ma J., Zhang P., Zhang T.D., Gazin C., Naoe T., Chen S.J., Wang Z.Y., Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 1996; 88: 1052–1061
   PubMed Web of Science ®Google Scholar
• Shao W., Fanelli M., Ferrara F.F., Riccioni R., Rosenauer A., Davision K., Lamph W.W., Waxman S., Pelicci P.G., Coco F.L., Avvisati G., Testa U., Peschle C., Gambacorti-Passeini C., Nervi C., Miller W.H., Jr. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J. Natl. Cancer Inst. 1998; 90: 124–133
   PubMed Web of Science ®Google Scholar
• Zhu J., Koken M.H.S., Quignon F., Chelbi-Alix M.K., Degos L., Wang Z.Y., Chen Z., de The H. Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 1997; 94: 3978–3983
   PubMed Web of Science ®Google Scholar
• Wang Z.G., Rivi R., Delva L., Konig A., Scheinberg D.A., Gambacorti-Passerini C., Gabrilove J., Warrell R.P., Jr., Pandolfi P.P. Arsenic trioxide and Melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner. Blood 1998; 92: 1497–1504
   PubMed Web of Science ®Google Scholar
• Akao Y., Mizoguchi H., Kojima S., Naoe T., Ohishi N., Yagi K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br. J. Haematol 1998; 102: 1055–1060
   PubMed Web of Science ®Google Scholar
• Akao Y., Nakagawa Y., Akiyama K. Arsenic induces apoptosis in neuroblastoma cell lines in vitro. FEBS letters 1999; 455: 39–62
   Web of Science ®Google Scholar
• Dai J., Weinberg S.R., Waxman S., Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999; 93: 268–277
   PubMed Web of Science ®Google Scholar
• Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamastu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50
   PubMed Web of Science ®Google Scholar
• Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 1994; 54: 2468–2471
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Shikano T., Maseki N., Sakurai M., Takeda T., Hiyoshi Y., Miyama J.-I., Fujimoto T. Clinical characteristics of infant acute leukemias with or without 11q23 translocations. Leukemia 1988; 2: 672–676
   PubMed Web of Science ®Google Scholar
• Akao Y., Mizoguchi H., Misiura K., Stec W.J., Seto M., Ohishi N., Yagi K. Antisense oligodeoxyribonucleotide against MLL-LTG19 chimeric transcript inhibits cell growth and induces apoptosis in an infantile leukemic cell line carrying the t(11;19) chromosomal translocation. Cancer Res. 1998; 58: 3773–3776
   PubMed Web of Science ®Google Scholar
• Larochette N., Decaudin D., Jacotot E., Brenner C., Marzo I., Susin S.A., Zamzami N., Xie Z., Reed J., Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res 1999; 249: 413–421
   PubMed Web of Science ®Google Scholar
• Chen Y.C., Lin Shiau S.Y., Lin J.K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell Physiol 1998; 177: 324–333
   PubMed Web of Science ®Google Scholar
• Cavigelli M., Li W.W., Lin A., Su B., Yoshioka K., Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 1996; 15: 6269–6279
   PubMed Web of Science ®Google Scholar
• Chen W., Martindale J.L., Holbrook N.J., Lin Y. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol. Cell Biol. 1998; 18: 5178–5188
   PubMed Web of Science ®Google Scholar
• Ishitsuka K., Hanada S., Suzuki S., Utsunomiya A., Chyuman Y., Takeuchi S., Takeshita T., Shimotakahara S., Uozumi K., Makino T., Arima T. Arsenic trioxide inhibits growth of human T-cell leukemia virus type I infected T-cell lines more effectively than retinoic acids. Br. J. Haematol. 1998; 103: 721–728
   PubMed Web of Science ®Google Scholar
• Bazarbachi A., El-Sabban M.E., Nasr R., Quignon F., Awaraji C., Kersual J., Dianoux L., Zermati Y., Haidar J.H., Hermine O., de The H. Arsenic trioxide and interferon-α synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood 1999; 93: 278–283
   PubMed Web of Science ®Google Scholar